Compare DHI & HLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DHI | HLN |
|---|---|---|
| Founded | 1978 | 2022 |
| Country | United States | United Kingdom |
| Employees | N/A | 24524 |
| Industry | Homebuilding | Package Goods/Cosmetics |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.0B | 41.1B |
| IPO Year | 1995 | N/A |
| Metric | DHI | HLN |
|---|---|---|
| Price | $154.09 | $9.13 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $166.08 | N/A |
| AVG Volume (30 Days) | 1.9M | ★ 8.3M |
| Earning Date | 04-21-2026 | 02-26-2026 |
| Dividend Yield | 1.19% | ★ 1.94% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.27 | N/A |
| Revenue | ★ $34,250,400,000.00 | N/A |
| Revenue This Year | $0.05 | $6.55 |
| Revenue Next Year | $5.85 | $4.42 |
| P/E Ratio | ★ $36.06 | $49.05 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $119.54 | $8.65 |
| 52 Week High | $183.62 | $11.28 |
| Indicator | DHI | HLN |
|---|---|---|
| Relative Strength Index (RSI) | 60.90 | 49.48 |
| Support Level | $149.23 | $8.99 |
| Resistance Level | $160.57 | $9.44 |
| Average True Range (ATR) | 4.02 | 0.13 |
| MACD | 1.13 | 0.03 |
| Stochastic Oscillator | 93.29 | 63.95 |
D.R. Horton is the largest homebuilder in the United States with operations in 126 markets across 36 states. D.R. Horton mainly builds single-family homes (over 90% of home sales revenue) and offers products to entry-level, move-up, luxury buyers, and active adults. The company offers homebuyers mortgage financing and title agency services through its financial services segment. The firm has majority ownership of Forestar Group, a publicly traded residential lot development company. D.R. Horton's headquarters are in Arlington, Texas.
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.